中國建材(03323.HK):北新建材年度淨利預增457.64%至512.04%
格隆匯 10 月 28日丨中國建材(03323.HK)公佈,公司A股附屬北新建材(000786.SZ)發佈2020年年度業績預告,預計年度歸屬於上市公司股東的淨利潤人民幣24.6億元至27億元,同比增長457.64%至512.04%,基本每股收益約1.456元至1.598元。
北新建材業績預計同向上升的主要原因是北新建材所屬子公司泰山石膏有限公司2019年與美國石膏板訴訟多區合併訴訟案多數原告達成和解併發生相關和解費用182,935.41萬元人民幣,該事項屬於非經常性損益;本年1至12月預計無大額和解費發生,導致歸屬於北新建材母公司淨利潤同比增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.